SCHEMBL6404855

SCHEMBL6404855

Cc1nnc(SCc2cccc(I)c2)[nH]1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.51
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 3/20 0.47
CDC7 O00311 1/20 0.46
DBF4 Q9UBU7 1/20 0.46
POLB P06746 1/20 0.43
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
HPGD P15428 4/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
LMNA P02545 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
TP53 P04637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408107 0.81 ALDH1A1 (0.67) MAOBALDH1A1POLBL3MBTL1TSHR
SCHEMBL6405550 0.79 MAOB (0.54) MAOBKDM4EALDH1A1CDC7DBF4
SCHEMBL6408555 0.76 CYP2D6 (0.45) MAOBKDM4EALDH1A1TSHRLMNA
SCHEMBL6406678 0.72 MAPK14 (0.47) MAOBKDM4EALDH1A1CDC7DBF4
SCHEMBL15928188 0.72 POLB (0.55) MAOBALDH1A1POLBHPGDLMNA
SCHEMBL3297899 0.68 IDO1 (0.48) MAOBCDC7DBF4CCNB2CDK1
SCHEMBL6408244 0.68 POLB (0.60) KDM4EALDH1A1POLBGSK3AGSK3B
SCHEMBL22288520 0.67 MAOB (0.50) MAOBALDH1A1CDC7DBF4CCNB2
SCHEMBL13635896 0.65 IDO1 (0.46) MAOBALDH1A1CDC7DBF4CCNB2
SCHEMBL6403337 0.64 SMN1; SMN2 (0.62) KDM4EALDH1A1POLBHPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT MAOB 361/4885KDM4E 3676/4885ALDH1A1 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.